Disclosure Panels Details Page
Central Nervous System Cancers Panel - Disclosures as of 02/13/2012
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mario Ammirati MD, MBA | NA | NA | NA | NA | ✔ |
| Philip Bierman MD | Seattle Genetics | None | None | None | ✔ |
| Henry Brem MD | None | None | None | None | ✔ |
| Nicholas Butowski MD | None | None | None | None | ✔ |
| Marc Chamberlain MD | NCCN Funded Bendamustine trial for Recurrent High-Grade Gliomas | Enzon Pharmaceuticals Exelixis Inc. Genentech, Inc. Schering-Plough Corporation |
None | None | ✔ |
| Lisa DeAngelis MD | None | Genentech, Inc. | None | None | ✔ |
| Robert Fenstermaker MD | None | None | None | None | ✔ |
| Allan Friedman MD | None | None | None | None | - |
| Lauren Gallagher | None | None | None | None | - |
| Mark Gilbert MD | RTOG Trial | Abbott Laboratories Genentech, Inc. Merck & Co., Inc. Pfizer Inc. Schering-Plough Corporation |
None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Deneen Hesser | None | None | None | None | ✔ |
| Maria Ho | None | None | None | None | - |
| Matthias Holdhoff MD, PhD | None | None | None | None | ✔ |
| Larry Junck MD | None | None | None | None | ✔ |
| Gerald Linette MD, PhD | None | Bristol Myers Squibb Genentech, Inc. GSK |
None | None | ✔ |
| Jay Loeffler MD | None | None | None | None | ✔ |
| Moshe Maor MD | None | None | None | None | ✔ |
| Joan McClure MS | None | None | None | None | - |
| Nicole McMillian MS | None | None | None | None | - |
| Madison Michael | None | None | None | None | ✔ |
| Paul Moots MD | ECOG EMD Sereno |
None | None | None | ✔ |
| Tara Morrison MD, FRCPC | None | Merck & Co., Inc. | None | None | ✔ |
| Maciej Mrugala MD, PhD, MPH | None | Enzon Pharmaceuticals Schering-Plough Corporation |
None | None | ✔ |
| Louis Nabors MD | AstraZeneca Pharmaceuticals LP Boehringer Ingelheim GmbH Eli Lilly and Company Genentech, Inc. GSK ImClone Systems Incorporated Merck KGaA Transmolecular |
Merck KGaA | None | None | ✔ |
| Herbert Newton MD | None | Eisai Inc. Schering-Plough Corporation UCB Pharma |
None | None | ✔ |
| Jana Portnow MD | None | None | None | None | ✔ |
| Jeffrey Raizer MD | Arno Genentech, Inc. MedImmune Inc. Millennium Pharmaceuticals, Inc. Myrixes Novartis Pharmaceuticals Corporation |
Enzon Pharmaceuticals Genentech, Inc. Geron Merck & Co., Inc. |
None | None | ✔ |
| Lawrence Recht MD | Celtic Pharmaceuticals Genentech, Inc. |
Genentech, Inc. | None | None | - |
| Dennis Shrieve MD, PhD | None | None | None | None | - |
| Allen Sills MD | None | Merck & Co., Inc. | None | None | ✔ |
| Nam Tran MD, PhD | None | None | None | None | ✔ |
| Frank Vrionis MD, PhD, MPH | Globus Synthes |
Florida Board of Medicine Orthofix Southeastern Brain Tumor Association |
None | None | ✔ |
| Patrick Wen MD | None | Genentech, Inc. | None | None | ✔ |